title: Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?
authors.affiliation: Department of Medicine, Center for Tuberculosis Research, Johns Hopkins University School of Medicine Baltimore, MD, USA.
authors.forename: Noton K
authors.initials: NK
authors.lastname: Dutta
authors.affiliation: Department of Medicine, Center for Tuberculosis Research, Johns Hopkins University School of Medicine Baltimore, MD, USA ; Department of International Health, Johns Hopkins Bloomberg School of Public Health Baltimore, MD, USA.
authors.forename: Petros C
authors.initials: PC
authors.lastname: Karakousis
keywords: Mycobacterium tuberculosis; animal models; clinical trial; persistence; reactivation; rifampicin; treatment improvement